Article Figures & Data
Figures
- Figure 1 Flowchart of the Study
- Figure 2 Progression of CASPR2-Encephalitis
(A) An overlap of the 3 main categories of neurologic symptoms in the patients: limbic (generalized or temporal lobe seizures, behavioral change, and/or memory impairment), peripheral nerve hyperexcitability (PNH), and cerebellar symptoms at the studied time points between onset and peak of the disease; and (B) over the entire study period (left panel) and at the last visit (right panel). The values represent the number of patients in each category. Patients who did not have symptoms of limbic encephalitis, cerebellar ataxia, or peripheral nerve hyperexcitability at 1 time point are not represented in the corresponding diagram. CASPR2 = contactin-associated protein-like 2.
- Figure 3 Fulfilment of the Graus Criteria14 for Definite Autoimmune Limbic Encephalitis and Completion of ≥3 and ≥4 of Van Sonderen CASPR2 Core Symptoms,11 Over Disease Course
There was no missing value. CASPR2 = contactin-associated protein-like 2.
- Figure 4 Outcomes of Patients With CASPR2-Encephalitis
(A) Progression of neurologic disability as assessed by the modified Rankin scale (mRS) score. There was no missing value. (B) Spider chart showing the medians of the 8 subscores of the SF-36 scale for quality of life, at the last visit. Thirty-five patients were included in this cross-sectional analysis, and their scores were compared with normative data from a French population of men older than 55 years. The axis represents the absolute values of the SF36 subscales, from the minimal to the maximal value of both our cohort and normative data, for each subscale. CASPR2 = contactin-associated protein-like 2; SF36 = 36-Item Short-Form Survey.
Tables
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
